Skip to main content
Equibles
HNGE logo

HNGE · Hinge Health, Inc.

Track HNGE — free

Use HNGE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$87.35 -5.50 (-5.92%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$7.05B
Shares
80.69M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$87.35 Open$92.00 Day$87.06–92.61 52W close$31.17–92.85 Avg vol 30d1.8M Short int5.6M · 7.0% float · 2.7d Short vol26% Last earningsAug 4, 2026 DataMay 2025–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.4 · calm Equity put/call 0.62
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +57%
      above
      Price vs 50-day avg +5%
      above
      RSI (14) 53
      neutral
      MACD trend Negative
      52-week position 91%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +17%
      trailing
      6-month return +90%
      trailing
      YTD return +88%
      this year
      Relative strength +77%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $83 › 200d $56 — 50d above 200d
      Institutional flow Accumulating
      +37% holders QoQ · +106 funds added
      Insider flow Distributing
      Net -$105.9K over 90 days · 100% sells
      Short interest Falling
      6.97% of float · ▼ -5.7% MoM · 2.7 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr high
      280 holders — near 1-yr high, broad support
      Squeeze score 67
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +51%
      Y/Y
      Gross margin 80%
      expanding
      EPS growth −783%
      Y/Y
      Free cash flow $170.7M
      Buyback $496.5M
      remaining
      Quant / Vol
      risk profile
      Very High
      Volatility 56%
      annualized · 1-yr
      Max drawdown −48%
      past year
      ATR 5.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 4 of last 4
      Latest guidance · from the 8-K filed Aug 4, 2026
      Q3 2026
      Revenue Maintained $223M – $225M
      Jun 30, 2026 $223M – $225M changed to Aug 4, 2026 $223M – $225M
      prior qtr $212.82M midpoint +5.3% QoQ
      Non-GAAP income from operations Non-GAAP Initiated $61M – $63M
      Non-GAAP operating margin Non-GAAP Initiated 28%
      Full Year 2026
      Revenue Maintained $856M – $860M
      Jun 30, 2026 $856M – $860M changed to Aug 4, 2026 $856M – $860M
      prior FY $587.86M midpoint +46.0% Y/Y
      Non-GAAP income from operations Non-GAAP Raised $236M – $244M
      May 5, 2026 $205M – $215M changed to Aug 4, 2026 $236M – $244M
      Non-GAAP operating margin Non-GAAP Raised 28%
      May 5, 2026 26% changed to Aug 4, 2026 28%
      Prior guidance period ended · from the 8-K filed May 5, 2026
      Revenue · Q2 2026 $194M – $196M
      Non-GAAP operating margin · Q2 2026 25%
      Guided vs delivered · last 4 settled
      Revenue Q2 2026
      guided $194M – $196M
      $212.82M Beat +9.1%
      Revenue Q4 2025
      guided $155M – $157M
      $170.73M Beat +9.4%
      Revenue Fiscal Year 2025
      guided $572M – $574M
      $587.86M Beat +2.6%
      Revenue Q3 2025
      guided $141M – $143M
      $154.21M Beat +8.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +57% Bullish
      Price vs 50-day avg
      +5% Bullish
      RSI (14)
      53 Neutral
      MACD trend
      Negative Bearish
      52-week position
      91% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $83 › 200d $56 — 50d above 200d
      Institutional flow Accumulating
      +37% holders QoQ · +106 funds added
      Insider flow Distributing
      Net -$105.9K over 90 days · 100% sells
      Short interest Falling
      6.97% of float · ▼ -5.7% MoM · 2.7 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr high
      280 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $31 Now $87 · 91% Range high $93
      vs 200-day avg +57% vs 50-day avg +5%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Non-GAAP gross profit non-GAAP $185.35M three months ended June 30, 2026 filing —
      GAAP → non-GAAP reconciliation
      GAAP GAAP gross profit 183.95M
      +1.13M Stock-based compensation expense
      +45K Employer payroll tax expense related to stock-based compensation
      +224K Amortization of intangible assets
      = Non-GAAP gross profit 185.35M
      LTM calculated billings $861.8M Q2 2026 —
      Number of clients 2,929 Q2 2026 —
      Annual yield 3.9% 2025 —
      LTM average eligible lives 20.1M as of December 31, 2025 —
      Number of members 782,890 as of December 31, 2025 —
      Rule of 40 metric 81 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HNGE
      Hinge Health, Inc.
      this stock
      		$7.05B +88.1% +50.6% — 7.0%
      VEEV
      Veeva Systems Inc
      		 $44.80B +23.9% +28.1% 45.3 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $11.70B +57.9% +28.2% 35.8 4.5%
      TEM
      Tempus AI, Inc.
      		 $11.56B +8.5% +83.4% — 16.6%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      280
      % held
      73.8%
      Net QoQ
      +2.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      182
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      5.6M
      Days to cover
      2.7d
      Change
      -337.2K sh
      View
      Short Volume
      Short vol %
      26%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      60
      Value
      $4.6K
      As of
      Jul 24, 2026
      View
      Off-Exchange
      Off-exchange %
      50.4%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$105.9K
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $587.9M
      Net income (FY)
      $-528.3M
      EPS diluted
      $-7.77
      View
      Buybacks
      Authorized
      $496.5M
      Remaining
      $496.5M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 21, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $6.0M
      Shares
      67.0K
      Filed
      Aug 28, 2026
      View
      Exempt Offerings
      Offering
      $400.0M
      Filed
      Dec 28, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 4, 2026
      View
      Investor Relations
      Latest news
      Hinge Health reports record secon…
      Published
      Aug 4, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      HNGE -1.2% +16.9% +89.9% +16.9% +88.1%
      SPY +0.5% +3.0% +13.4% +3.0% +12.8%
      vs SPY -1.7% +13.9% +76.5% +13.9% +75.2%

      Capital returns

      Buyback program · as of Jul 29, 2026
      Authorized
      $496.50M
      Spent (derived)
      $0
      Remaining
      $496.50M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1673743 CUSIP 433313103 13F (30d) 251 filings 251 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)